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The Vesicle-associated membrane protein (VAMP)-Associated Protein B (VAPB) is the causative gene of amyo-
trophic lateral sclerosis 8 (ALS8) in humans. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegen-
erative disease characterized by selective death of motor neurons leading to spasticity, muscle atrophy and
paralysis. VAP proteins have been implicated in various cellular processes, including intercellular signalling,
synaptic remodelling, lipid transport and membrane trafficking and yet, the molecular mechanisms underlying
ALS8 pathogenesis remain poorly understood. We identified the conserved phosphoinositide phosphatase
Sac1 as a Drosophila VAP (DVAP)-binding partner and showed that DVAP is required to maintain normal
levels of phosphoinositides. Downregulating either Sac1 or DVAP disrupts axonal transport, synaptic growth,
synaptic microtubule integrity and the localization of several postsynaptic components. Expression of the dis-
ease-causing allele (DVAP-P58S) in a fly model for ALS8 induces neurodegeneration, elicits synaptic defects
similar to those of DVAP or Sac1 downregulation and increases phosphoinositide levels. Consistent with a
role for Sac1-mediated increase of phosphoinositide levels in ALS8 pathogenesis, we found that Sac1 downre-
gulation induces neurodegeneration in a dosage-dependent manner. In addition, we report that Sac1 is seques-
tered into the DVAP-P58S-induced aggregates and that reducing phosphoinositide levels rescues the
neurodegeneration and suppresses the synaptic phenotypes associated with DVAP-P58S transgenic expres-
sion. These data underscore the importance of DVAP–Sac1 interaction in controlling phosphoinositide metab-
olism and provide mechanistic evidence for a crucial role of phosphoinositide levels in VAP-induced ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive, degen-
erative disorder characterized by the selective loss of motor
neurons in the brain and spinal cord leading to paralysis,
muscle atrophy and eventually, death (1). Two missense muta-
tions in the gene encoding the human Vesicle-associated mem-
brane protein (VAMP)-Associated Protein B (hVAPB) causes
a range of dominantly inherited motor neuron diseases includ-
ing ALS8 (2,3). VAP family proteins are characterized by an
N-terminal major sperm protein (MSP) domain, a coiled-coil
(CC) motif and a transmembrane (TM)-spanning region.
They are implicated in several biological processes, including
regulation of lipid transport, endoplasmic reticulum (ER)
morphology and membrane trafficking (4). Drosophila
Vap-33-1 (hereafter, DVAP) regulates synaptic structure,
synaptic microtubule (MT) stability and the composition of
postsynaptic glutamate receptors (5,6). MSP domains in
DVAP are cleaved and secreted into the extracellular space
where they bind Ephrin receptors (7). MSPs also bind postsy-
naptic Roundabout and Lar-like receptors to control muscle
mitochondria morphology, localization and function (8).
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Transgenic expression of the disease-linked alleles
(DVAP-P58S and DVAP-T48I) in the larval motor system
recapitulates major hallmarks of the human disease, including
aggregate formation, locomotion defects and chaperone upre-
gulation (3,6,9). Several studies have also implicated the
ALS mutant allele in abnormal unfolded protein response
(UPR) (3,10–13) and in the disruption of the anterograde
axonal transport of mitochondria (14). However, it is unclear
how these diverse VAP functions are achieved and which
mechanisms underlie the disease pathogenesis in humans.
One way to address these questions is to search for
DVAP-interacting proteins. We identified Sac1 (Suppressor
of Actin 1), an evolutionarily conserved phosphoinositide
phosphatase, as a DVAP-binding protein. Phosphoinositides
are low-abundance lipids that localize to the membrane–cyto-
plasm interface and function by binding various effector pro-
teins. The inositol group can be reversibly phosphorylated at
the 3′, 4′ and 5′ positions to generate seven possible phosphoi-
nositide derivatives, each with a specific intracellular dynamic
distribution (15). Sac1 predominantly dephosphorylates
PtdIns4P pools, although PtdIns3P and PtdIns(3,5)P2 can
also function as substrates (16). In yeast, Sac1 has been
linked to several processes, including actin organization,
vacuole morphology and sphingomyelin synthesis (17,18).
Drosophila Sac1 mutants die as embryos and exhibit defects
in dorsal closure and axonal pathfinding (19,20). Mouse
lines deficient for Sac1 are cell lethal, whereas Sac1 downre-
gulation in mammalian cell cultures results in disorganization
of Golgi membranes and mitotic spindles (21). Interestingly,
SAC3 (also known as FIG4), another member of the Sac phos-
phatase family, is mutated in familial and sporadic cases of
ALS (22). Inactivation of SAC3 in mice also results in exten-
sive degeneration and neuronal vacuolization in the brain,
most relevantly in the motor cortex (23). We identified Sac1
and DVAP as binding partners and show that DVAP is
required to maintain normal levels of PtdIns4P. Loss of
either Sac1 or DVAP function disrupts axonal transport, MT
stability, synaptic growth and the localization of a number
of postsynaptic markers. We also show that the disease-
causing mutation (DVAP-P58S) induces neurodegeneration
and displays synaptic phenotypes similar to those of either
Sac1 or DVAP loss-of-function, including an increase in
PtdIns4P levels. Importantly, reducing PtdIns4P levels
rescues the neurodegeneration associated with DVAP-P58S
and suppresses the synaptic phenotypes associated with
DVAP-P58S and DVAP loss-of-function alleles. Consistent
with these observations, Sac1 is sequestered into DVAP-
P58S-mediated aggregates and downregulation of Sac1 in
neurons induces increased PtdIns4P levels and degeneration.
These data highlight the crucial role of DVAP and Sac1 in
regulating phosphoinositides and support a causative role for
PtdIns4P levels in ALS8 pathogenesis.
RESULTS
DVAP physically interacts with Sac1
A previous yeast two-hybrid screen for large-scale mapping of
protein–protein interactions in Drosophila identified Sac1 as a
DVAP-interacting protein (24). We confirmed this by yeast
two-hybrid binary interaction and co-immunoprecipitation
assays. A yeast two-hybrid analysis to detect a binary inter-
action between DVAP and Sac1 showed that these proteins
can bind each other and that both the disease-causing alleles
DVAP-P58S and DVAP-T48I retained their ability to bind
Sac1 (Fig. 1A). For the co-immunoprecipitation assays,
Myc-tagged Sac1 and Flag-tagged DVAP constructs were
transfected in COS7 cells. In cell extracts expressing both
Myc-tagged Sac1 and Flag-tagged DVAP, Flag-DVAP was
clearly co-immunoprecipitated with Myc-Sac1 by the
anti-Myc antibody. In agreement with the yeast two-hybrid
data, Flag-DVAP-P58S was also significantly co-immunopreci-
pitated with Myc-Sac1. As a control, little co-immunoprecipi-
tation was observed using cell extracts expressing either
Flag-DVAP or Flag-DVAP-P58S but not Myc-Sac1 (Fig. 1B).
To further extend this analysis, we mapped the interaction
domains on both proteins by yeast two-hybrid assay. Sac1 con-
tains a conserved phosphoinositide–phosphatase module
termed the Sac domain, comprising seven highly conserved
motifs, including the catalytic domain. It also contains an N-
terminal leucine zipper motif and two C-terminal putative
TM domains, TM1 and TM2. We found that whereas TM2
was dispensable for the binding activity of Sac1, truncation
of the first 18 amino acids encompassing the b1 helix effect-
ively abolished Sac1 binding to DVAP (Fig. 1C). DVAP
also exhibits conserved structural domains, including the
MSP domain, a CC motif and a TM domain. Surprisingly,
we found that the MSP domain was dispensable for the inter-
action, whereas removal of the C-terminal TM domain abol-
ished the ability of DVAP to physically interact with Sac1
(Fig. 1D). Collectively, our data indicate that DVAP binds
Sac1 via its TM and that a Sac1 fragment of 546 amino
acids lacking the most C-terminal TM is necessary to bind
DVAP. These data also show that ALS8-causing mutations
do not affect the ability of DVAP to bind Sac1.
Presynaptic Sac1 is required for synaptic morphology, MT
organization and axonal transport
Since DVAP and Sac1 physically interact, we asked whether
mutations in Sac1 could affect the same biological processes
as those affected by mutations in DVAP. DVAP loss-of-func-
tion mutations lead to a synaptic phenotype at the larval neuro-
muscular junction (NMJ) characterized by a reduction in the
number of boutons and an increase in their size (5). Strong
hypomorphic mutations in Sac1 cause embryonic lethality
due to an early requirement of the gene during development
(19). We therefore undertook a transgenic RNA interference
(RNAi) approach to reduce Sac1 protein level during postem-
bryonic development from the presynaptic side. We selective-
ly expressed Sac1RNAi in neurons, using the UAS-Gal4
system and the neuronal-specific driver elav-Gal4. Staining
with anti-HRP antibodies that label and allow for visualization
of synaptic terminals showed that reducing Sac1 expression in
presynaptic cells (elav;Sac1RNAi) led to a decrease in bouton
number (181+ 3.9 versus 280+ 4.6 in controls) and a con-
comitant increase in their size (Fig. 2A and C and Supplemen-
tary Material, Fig. S1A and B). To dissect the cell-specific role
of DVAP, we downregulated DVAP expression in presynaptic
cells, using DVAPRNAi lines and the elav-Gal4 driver.
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Presynaptic knockdown of DVAP (elav;DVAPRNAiGD3990)
induced a synaptic morphological phenotype similar to those
of DVAP null mutations (5) and presynaptic Sac1RNAi expres-
sion (Fig. 2A–C and Supplementary Material, Fig. S1A and B).
The presynaptic MT cytoskeleton, as visualized by staining
with antibodies specific for the MAP1B-like protein Futsch, is
severely perturbed in DVAP mutant NMJs (5). We tested
whether Sac1 or DVAP downregulation in neurons affected
MT stability at the NMJ. In control NMJs, MTs run mainly
as a filament of Futsch staining across the nerve terminal
branches (Fig. 2A). Occasionally, Futsch staining appears
punctuate or splayed into a number of thinner filaments
filling up the entire volume of the boutons. These two forms
of staining, i.e. ‘punctuate and splayed’ have been described
as two variant forms of disorganized MTs found in mutants
affecting synaptic architecture (25,26). At both elav;Sac1RNAi
and elav;DVAPRNAiGD3990 NMJs, there was an increase in the
number of boutons showing MT disorganization. Although in
controls the percentage of boutons exhibiting the ‘filled’ or
‘diffuse’ pattern of Futsch staining was only 35.7+ 1.4, the
number of boutons with the same pattern in elav;Sac1RNAi
and elav;DVAPRNAiGD3990 NMJs was 58.3+ 1.7 and
70.5+ 2.4%, respectively (Fig. 2B and C; Supplementary Ma-
terial, Fig. S1C).
Although the axonal MT cytoskeleton had no obvious mor-
phological defects (data not shown), we observed abnormal-
ities in the distribution of proteins and synaptic vesicles
along the nerves. At control NMJs, Bruchpilot (Brp), an essen-
tial component of the synaptic active zones (27), was barely
detectable along the nerves (Fig. 2D). Conversely, both
elav;DVAPRNAiGD3990 and elav;Sac1RNAi mutants exhibited
massive accumulation of Brp aggregates along the axons
(Fig. 2E and F, Supplementary Material, Fig. S1D). Similar
aggregates were observed using antibodies specific for the
vesicle-associated cysteine string protein (data not shown).
Hence, these results indicate that DVAP and Sac1 exhibit
functional similarity and control several aspects of NMJ physi-
ology, including synaptic structure, axonal transport and MT
organization.
Postsynaptic downregulation of either Sac1 or DVAP
affects synaptic morphology and the distribution of several
synaptic markers
To assess the postsynaptic function of Sac1, we focused on
two phosphoinositide-dependent proteins, adducin and
b-spectrin, both with established NMJ function and involve-
ment in ALS pathogenesis or neurodegeneration (28–31).
The muscle-specific driver BG57-Gal4 was used to express
either Sac1RNAi or DVAPRNAi transgene postsynaptically. In
controls, synaptic boutons had a rounded to oval appearance
and were separated from each other by a well-defined neural
process (Fig. 3A). Adducin, a predominantly postsynaptic
marker, colocalized with and surrounded the presynaptic mem-
brane defined byHRP staining (Fig. 3A). In bothBG57/DVAPR-
NAiGD3990 and BG57;Sac1RNAimutants, a complex phenotype
affecting both the pre- and postsynaptic compartments was
observed. The most striking effect was an aberrant synaptic
Figure 1. Sac1 interacts with both DVAP and DVAP-P58S. (A) Sac1 interaction with DVAP and DVAP-P58S by yeast two-hybrid assay. p53/T-Ag interaction
is the positive control and the lack of interaction between T-Ag and Lamin (LAM) is used as a negative control. Sac1 interacts with DVAP as well as with
DVAP-P58S and DVAP-T48I. AD, Gal4 activation domain. DB, Gal4 DNA-binding domain. (B) Co-immunoprecipitation of Myc-Sac1 and Flag-DVAP or
Flag-DVAP-P58S from cell lysates transfected with the indicated plasmids. Immunoprecipitates were collected on anti-Myc Sepharose beads. Input (I), immu-
noprecipitated complexes indicated as pellet (P) and the unbound fractions indicated as supernatant (S) were analysed by western blots with antibodies to DVAP
or Myc. (C) DVAP interaction with Sac1-truncated proteins. LZ, leucine zipper; CD, catalytic domain; TM1,TM2, transmembrane domains 1, 2. On the right
column, interactions (Int) are indicated by plus signs and lack of interaction by minus signs. In (D), Sac1 interaction with DVAP-truncated proteins is reported.
MSP, major sperm protein; CC, coiled coil; TM, transmembrane domains. Interactions (Int) are indicated by plus signs and lack of interaction is indicated by
minus signs. The CC domain (amino acids 184–227) and the TM domain (amino acids 250–266) were deleted from DVAP.
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morphology, although the number of boutons remained nearly
normal. Boutons were larger and exhibited a highly irregular
shape with a number of spike-like protrusions emerging from
their contours. Remarkably, a mismatched apposition between
the presynaptic membrane visualized by the HRP staining and
the postsynaptic marker adducin was observed in mutants
when compared with controls (Fig. 3B andC). At the postsynap-
tic compartment, adducin no longer tightly associated with the
presynaptic boutons to entirely circumscribe the presynaptic
membrane as in controls but it appeared confined to specific
subregions of the membrane and absent or diffused in others
(Fig. 3B and C). Similar phenotypes were observed for
b-spectrin (Supplementary Material, Fig. S2A–C). Moreover,
the postsynaptic localization of Discs-Large (DLG), the Dros-
ophila homologue of the mammalian PSD-95, has been shown
to depend on both adducin and b-spectrin (32,33). As expected,
in both DVAPRNAiGD3990 and Sac1RNAi muscles, DLG was
not surrounding the perimeter of the boutons but appeared
rather disorganized and diffused (Supplementary Material,
Fig. S2D–F). A high degree of heterogeneity among the
different phenotypic classes was observed; however, the most
abnormal bouton branches were those with the most aberrant
organization in the distribution and localization of the adducin
and b-spectrin postsynaptic markers. This is in agreement
with previous data reporting that disruption of the
actin–spectrin postsynaptic cytoskeleton can affect the shape
and the appearance of presynaptic boutons (34). DVAP null
alleles do not exhibit the morphological phenotype associated
with postsynaptic downregulation of DVAP. A possible cause
for this apparent discrepancy could be the non-cell autonomous
effect of DVAP (7), as in this case phenotypic outcomes do not
simply depend on the genotype of a mutant cell but may be also
affected by the genotype of neighbouring cells.
It is well known that off-target activity can complicate
the interpretation of phenotypic effects in gene silencing
experiments by RNAi. To test the specificity of Sac1 knock-
down by RNAi, we showed that expression of the Sac1RNAi
construct in larval brains resulted in an almost complete deple-
tion of Sac1 RNA (Supplementary Material, Fig. S3A). To
exclude the possibility of off-target effects, we performed a
phenotypic analysis of larvae expressing a Sac1 transgenic
line (DSac1) in which the –RTNCIDCLDRTN– catalytic
site has been removed. Expression of the DSac1 transgenic
line in a wild-type background should have a dominant nega-
tive effect and should exhibit mutant phenotypes similar to
those of a Sac1 loss-of-function allele. As expected, targeting
the expression of DSac1 allele either pre- or postsynaptically
led to a phenotype similar to those associated with Sac1
downregulation by Sac1RNAi (Supplementary Material,
Fig. S3B–G).
Figure 2. Presynaptic Sac1 and DVAP are required for synaptic morphology, MT integrity and axonal transport. (A–C) Representative confocal images of
muscle 12 synapses stained for both HRP and Futsch in elav-Gal4/+ controls (A), elav;DVAPRNAiGD3990 larvae (B) and elav;Sac1RNAi transgenic mutants
(C). elav;DVAPRNAiGD3990 and elav;Sac1RNAi NMJs exhibit a significant increase in the number of boutons with splayed (arrow) and lack or punctuate (arrow-
head) Futsch staining. (D–F) Representative confocal images of nerves stained for both HRP and Bruchpilot (Brp) in controls (D), elav;DVAPRNAiGD3990
(E) and elav;Sac1RNAi transgenic larvae (F). Bar ¼ 10 mm.
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For DVAP, two RNAi lines are available: DVAPRNAiGD3990
from the VDRC (Vienna Drosophila RNAi Center) collection
and DVAPRNAiJF02621 from the TRiP collection. These lines
were generated using constructs containing inverted repeats
that target different, non-overlapping sequences within
DVAP (see Materials and Methods for details). The DVAPR-
NAiGD3990 line effectively knocks down DVAP expression in
salivary glands and brains from progeny of elav-Gal4 flies
crossed to DVAPRNAiGD3990 flies (Supplementary Material,
Fig. S4). A similar decrease in DVAP levels was associated
with transgenic expression of DVAPRNAiJF02621 in the same
tissues (data not shown). In addition, either pre- or postsynap-
tic expression of DVAPRNAiJF02621 induced mutant pheno-
types reminiscent of those associated with DVAPRNAiGD3990
transgenic expression (Supplementary Material, Fig. S5). To-
gether, these data indicate that for both DVAP and Sac1,
gene knockdown by RNAi was specific and exclusively
affected the intended genes.
Studies in Drosophila have suggested that DVAP-P58S
could act as a dominant negative allele by sequestering wild-
type DVAP into aggregates and depleting it from its normal
localization (6,9). If this holds true for the DVAP–Sac1 inter-
action as well, then DVAP-P58S flies should exhibit mutant
phenotypes similar to both DVAP and Sac1 downregulation.
Indeed, the mutant phenotypes associated with both pre- and
postsynaptic expression of DVAP-P58S (Supplementary Ma-
terial, Figs S1, S6 and S7) were highly similar to those of
DVAPRNAi and Sac1RNAi in the same tissues, thus confirm-
ing the proposed genetic effect of the DVAP-P58S allele.
The phenotypes associated with synaptic downregulation of
Sac1 are highly reminiscent of those of DVAPRNAi mutants,
suggesting that DVAP and Sac1 function in the same pathway.
To assess additive effects, we focused on the easily quantifiable
presynaptic morphology phenotype. Both elav;Sac1RNAi and
elav;DVAPRNAiGD3990 exhibited a reduction in bouton
number with a concomitant increase in their size. We noticed
that elav;DVAPRNAiGD3990;Sac1RNAi double mutants did not
show any further severity in the phenotype when compared
with either single mutant alone (Supplementary Material, Fig
S8). Taken together, these data indicate that Sac1 and DVAP
do indeed function in a common pathway.
Sac1 colocalizes with DVAP in vivo
To assess the expression pattern of Sac1 in vivo, we generated
antibodies against two subfragments of the protein. However,
these antibodies performed rather poorly, so we generated trans-
genic flies expressing a functional Flag-Sac1 construct, which
rescued the lethality of Sac12107 mutants and facilitated Sac1
localization using Flag-specific antibodies. We found that
both Sac1 and DVAP proteins colocalized in larval brains, eye
imaginal discs and salivary glands (Supplementary Material,
Fig. S9A, C and D). DVAP and Sac1 closely associated in
muscles where they colocalized in a perinuclear region (Supple-
mentary Material, Fig. S9B) that has been previously shown to
correspond to the ER/sarcoplasmic reticulum (3).
In yeast and mammalian cells, Sac1 associated with the ER
and the Golgi (35,36). To define the subcellular localization of
Drosophila Sac1, we cotransfected Flag-Sac1 and Myc-DVAP
constructs in COS-7 cells. Staining with antibodies specific for
DVAP and Flag revealed a considerable overlap of the two
proteins in a reticular pattern that previous studies showed to
be the region where DVAP overlapped with ER-specific
markers (3). Sac1 also localized to a paranuclear region corre-
sponding to the Golgi complex. DVAP staining appeared to be
excluded from this region, confirming that DVAP was pre-
dominantly an ER-associated protein (Supplementary Mater-
ial, Fig. S9E). Finally, to define the subcellular localization
of Sac1 in vivo, we targeted expression of Flag-Sac1 in saliv-
ary glands. Consistent with the COS-7 data, Sac1 partially
Figure 3. Postsynaptic downregulation of either DVAP or Sac1 induces changes in bouton morphology and adducin disorganization. (A–C) Representative
confocal images of larval NMJs stained for HRP and adducin in BG57-Gal4/+controls (A), BG57/DVAPRNAi GD3990 transgenic mutants (B) and BG57;Sac1R-
NAi transgenic mutants (C). Asterisks indicate big and irregular boutons; arrowheads point to spikes; triangles show mismatched apposition of pre- and post-
synaptic components and arrows indicate diffused and missing adducin staining. Bar ¼ 10 mm.
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colocalized with both the ER marker Boca (37) and the cis-
cisternal Golgi marker GM130 (Supplementary Material,
Fig. S10). In summary, these data indicate that DVAP and
Sac1 colocalize in all the tissues examined. Moreover, Sac1,
like its yeast and mammalian homologues, associates with
subcellular compartments corresponding to both the Golgi
and the ER.
DVAP function is required to maintain normal PtdIns4P
levels
In mammals, Sac1 controls PtdIns4P levels in the ER and in the
Golgi, and in yeast, it can also modulate PtdIns4P associated
with the plasma membrane (PM) (17,38). In yeast, VAP is
required for Sac1 activity, and in VAP mutants PtdIns4P levels
are increased (39). If such a mechanismwere conserved inDros-
ophila, then one would also expect an increase in PtdIns4P levels
in DVAPRNAiGD3990 mutants. We first stained larval salivary
glands with a PtdIns4P antibody. In control cells, PtdIns4P was
mainly detected at the PM, while under these staining conditions
the intracellular pool was barely detectable. In contrast, both
elav;Sac1RNAi and elav;DVAPRNAiGD3990 salivary glands
exhibited increased PtdIns4P levels, particularly intracellularly
(Supplementary Material, Fig. S11A). In control brains and
muscles, PtdIns4P levels were basically below our detection
limit (Supplementary Material, Fig. S11B and C). However, in
Sac1RNAi and DVAPRNAiGD3990 brains, the expression levels
of PtdIns4P were dramatically increased (Supplementary Mater-
ial, Fig. S11B). InBG57;Sac1RNAi andBG57/DVAPRNAiGD3990
muscles, a similar increase in PtdIns4P levelswas observed (Sup-
plementary Material, Fig. S11C). These results support a role for
DVAP in PtdIns4P metabolism, potentially by controlling Sac1
phosphatase function.
The mutant phenotypes associated with both pre- and postsy-
naptic expression of DVAP-P58S (Supplementary Material,
Figs S1, S6 and S7) were highly similar to those of DVAPRNAi
and Sac1RNAi in the same tissues. We should expect then to
observe increased PtdIns4P levels in DVAP-P58S flies. Indeed,
PtdIns4P levels were dramatically elevated in salivary glands,
brains and muscles expressing the DVAP-P58S transgene (Sup-
plementary Material, Fig. S11A–C). Finally, we showed that in
every genotype the increase in PtdIns4P levels was not accom-
panied by a significant upregulation of PtdIns(4,5)P2, suggesting
that the observed phenotypes are unlikely to be mediated by an
upregulation of PtdIns(4,5)P2 (Supplementary Material,
Fig. S12). Hence, these data indicate that DVAP function is
required for PtdIns4P metabolism at the NMJ and that transgenic
expression of ALS-causing mutations associates with an upregu-
lation of PtdIns4P levels both in neurons and muscles.
Downregulation of Sac1 in neurons causes
dosage-dependent neurodegeneration
Flies expressingDVAP-P58S in the adult nervous system fail to
eclose, whereas targeted expression of DVAP-P58S in the eye
induces extensive neurodegeneration, characterized by
reduced eye size, with disorganized ommatidia showing missing,
irregular or supernumerary bristles (3). As DVAP-P58S expres-
sion induces an increase in PtdIns4P levels and causes extensive
neurodegeneration, one would expect the same outcome from
Sac1 downregulation in neurons.
To test this hypothesis, we downregulated Sac1 in the
nervous system, using the elav-Gal4 driver (elav;Sac1RNAi).
Accordingly, elav;Sac1RNAi flies failed to eclose in 60% of
individuals, whereas survivors exhibited marked neurodegen-
eration in the eye. The extent of neurodegeneration was,
however, different in males and females. Females displayed
extensive depigmentation, whereas males had the majority of
the eye surface covered by patches of severe necrosis
(Fig. 4A). The necrotic patch phenotype was fully penetrant
as it was observed in 100% of males; however, differences
in the degree and extent of the necrotic regions could be
seen. The gender difference was consistent with higher
levels of elav-Gal4 expression in males than in females
owing to the X-chromosome dosage compensation effect in
males (40). No difference in eye tissue survival between
elav-Gal4 females and males was observed, indicating that
the degenerative phenotype was not dependent on differences
in gender or expression of Gal4 alone. Scanning electron
micrographs of male eyes showed extensive regions of fused
ommatidia and missing or misoriented interommatidial bristles
(Fig. 4B). Eye sections showed a severe disruption in retinal
organization, with thinning of the retina and loss of retinal
neurons (Fig. 4C). This degenerative phenotype correlated
with increased levels of PtdIns4P in elav;Sac1RNAi eye imagi-
nal discs (data not shown).
In Sac1 mutant clones, activation of pro-apoptotic caspase 3
is suppressed by simultaneously overexpressing the Drosoph-
ila Inhibitor of Apoptosis 1 (DIAP1) gene (41). Likewise,
DIAP1 overexpression strongly suppressed the reduction in
eye size associated with DVAP-P58S expression in the eye.
This suppression was not due to a dilution of Gal4, as coex-
pression of a GFP transgene had no effect (Supplementary
Material, Fig. S13). These data indicate that in both cases neu-
rodegeneration was, at least in part, due to death by apoptosis.
In conclusion, these data demonstrate that Sac1 downregula-
tion induces neurodegeneration in a dosage-dependent
manner and that a similar phenotype is associated with trans-
genic expression of DVAP-P58S in neurons.
Upregulation in PtdIns4P levels induces
DVAP-P58S-associated synaptic phenotypes
and neurodegeneration
Our data so far indicate that upregulation of PtdIns4P could be
a major cause of DVAP-P58S-mediated neurodegeneration. If
this were true, then one would expect that blocking PtdIns4P
production by downregulating either of the two PtdIns-
kinases, PI4KIIIa and Four-wheel drive (Fwd), should sup-
press neurodegeneration. Coexpressing either FwdRNAi or
PI4KIIIaRNAi transgenes in ey,DVAP-P58S recombinant
flies markedly attenuated the neurodegenerative phenotype.
Specifically, the structural phenotypes and 50% size reduc-
tion in ey,DVAP-P58S eyes were significantly suppressed in
both ey,DVAP-P58S/PI4KIIIaRNAi and ey,DVAP-P58S;FwdRNAi
flies (Fig. 5). This suppression was not due to a dilution ofGal4,
as coexpression of a GFP transgene had no effect (Supplemen-
tary Material, Fig. S13).
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To directly confirm the role of PtdIns4P in DVAP-P58S-
induced neurodegeneration, we assessed PtdIns4P levels in
eye imaginal discs of ey,DVAP-P58S; ey,DVAP-P58S/
PI4KIIIaRNAi and ey,DVAP-P58S;FwdRNAi. A marked in-
crease in PtdIns4P levels was observed in ey,DVAP-P58S
eye imaginal discs, whereas PtdIns4P levels were reduced
and similar to wild-type in ey,DVAP-P58S/PI4KIIIa RNAi
and ey,DVAP-P58S;FwdRNAi animals (Fig. 6A, B, D and E).
The decrease in the PtdIns4P levels was not a consequence of di-
luting the Gal4, as coexpression of a GFP transgene with
DVAP-P58S had no effect (Fig. 6C).
Synaptic phenotypes associated with the expression of
DVAP-P58S in the motor system could also be due to an upre-
gulation of PtdIns4P and therefore knocking down either Fwd
or PI4KIIIa kinase should suppress DVAP-P58S-mediated
phenotypes. In both cases, the motor neuron-specific driver
OK6-Gal4 was used. We found that the NMJ phenotypes of
OK6;DVAP-P58S were significantly rescued by coexpressing
the FwdRNAi transgene (Fig. 7). A similar effect was observed
when PI4KIIIaRNAi was expressed in motor neurons together
with DVAP-P58S (data not shown). In addition, the effect of
coexpressing FwdRNAi and DVAP-P58S transgenes in
muscles (BG57/DVAP-P58S;FwdRNAi) was assessed. Inter-
estingly, we found that BG57/DVAP-P58S;FwdRNAi NMJs
did not resemble wild-type but rather NMJs expressing
BG57;FwdRNAi alone. Specifically, NMJs exhibited an abnor-
mal structure and were composed mainly of a few fused
boutons lacking their characteristic smooth and round shape.
These boutons appeared deformed, with elongated and missha-
pen profiles (Supplementary Material, Fig. S14A–C). This
phenotypic similarity suggests that FwdRNAi expression in
BG57/DVAP-P58S postsynaptic terminals decreased
PtdIns4P below wild-type levels. An analogous effect was
observed when PI4KIIIaRNAi transgene was expressed in
BG57/DVAP-P58S muscles (data not shown). Interestingly,
we found that presynaptic and postsynaptic coexpression of
FwdRNAi transgene in DVAPRNAiGD3990 NMJs had a
similar effect, further supporting the importance of PtdIns4P
levels in DVAP-mediated function (Supplementary Material,
Figs S15 and S14D, respectively). In conclusion, these data
provide strong evidence for a direct role of PtdIns4P upregula-
tion in DVAP-P58S-mediated neurodegeneration and synaptic
phenotypes.
Sac1 is sequestered in DVAP-P58S-induced aggregates
Our biochemical data and the analysis of mutant phenotypes in-
dicate that ALS8 is due to DVAP loss-of-function, with Sac1
being downregulated and PtdIns4P levels subsequently increas-
ing. However, our biochemical analysis also showed that both
ALS8 mutations retain their ability to bind Sac1. How then is
Sac1 function impaired in DVAP-P58S mutants? To address
this question, we coexpressed a Flag-Sac1 transgene in
ey-Gal4,DVAP-P58S recombinant flies and stained eye imagi-
nal discs with antibodies specific for Flag and DVAP. We
have previously shown that DVAP-P58S-mediated aggregates
contain wild-type and mutant DVAP proteins that are both
immunoreactive to DVAP-specific antibodies (3). We observed
that, in larval eye imaginal discs, Sac1 was sequestered in the
DVAP-P58S-mediated inclusions and was depleted from its
normal localization (Fig. 8A). Similarly, in elav;DVAP-P58S;
Flag-Sac1 larval brains, Sac1 appeared to be recruited into
DVAP-P58S-mediated aggregates (Fig. 8B). This was in con-
trast to the diffuse and granular pattern of Sac1 staining
observed in controls (Supplementary Material, Fig. S9A and
C). In both instances, the association of Flag-Sac1 with the
aggregates was specific since a coexpressed GFP was not
recruited into the aggregates (data not shown). In conclusion,
our data indicate that the DVAP–Sac1 interaction regulates
PtdIns4P levels and support a model whereby sequestering Sac1
and DVAP into pathogenic aggregates compromises the function
of both proteins, leading to an increase in PtdIns4P levels.
DISCUSSION
Here we identified Sac1 as a DVAP-binding protein and
uncovered a hitherto unknown function of Sac1 in postem-
bryonic synaptic maturation and neurodegeneration. Presynap-
tic reduction of either DVAP or Sac1 levels induces structural
changes, disruption of the synaptic MT cytoskeleton and accu-
mulation of clusters of proteins and vesicles along the axons.
In addition, muscle down-regulation of either Sac1 or DVAP
leads to a strikingly aberrant synaptic morphology and abnor-
mal localization and distribution of several postsynaptic
markers, including adducin and b-spectrin. We also report
Figure 4. Downregulation of Sac1 in the eye induces neurodegeneration in a
dosage-dependent manner. (A) Stereo microscope images of control
(elav-Gal4/+), elav;Sac1RNAi male and elav;Sac1RNAi female adult eyes.
(B) Scanning electron micrographs of control and elav;Sac1RNAi transgenic
eyes of adult males. Although the adult Drosophila eye is composed of an
ordered array of ommatidia with interspersed, regularly oriented bristles, trans-
genic eyes exhibit extensive regions of fused ommatidia (black arrow), with
missing (black arrow) and misoriented bristles (white arrow). (C) Frontal sec-
tions of control and elav;Sac1RNAi transgenic eyes of adult males. The arrow-
head points to tissue degeneration. Bar ¼ 10 mm in (B) and 50 mm in (A)
and (C).
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that depletion of DVAP as well as Sac1 expression induces an
increase in PtdIns4P levels.
We go on to show that Sac1 downregulation in the adult
nervous system causes early death and neurodegeneration in
a dosage-dependent manner, a phenotype similar to that of
DVAP-P58S transgenic expression. Our analysis indicates
that the DVAP-P58S allele has a dominant negative effect,
as its transgenic expression leads to an upregulation of
PtdIns4P and its mutant phenotypes are similar to those asso-
ciated with either DVAP or Sac1 loss-of-function. In agree-
ment with the hypothesis that neurodegeneration in the
DVAP-P58S context is due to a loss-of-function of both
DVAP and Sac1, we report that both wild-type DVAP and
Sac1 are depleted from their normal localization and are
sequestered into DVAP-P58S-mediated aggregates.
Altogether, these data are consistent with a model in which
DVAP is required for Sac1 activity and for the regulation of
intracellular PtdIns4P levels. Loss-of-function of DVAP and
Sac1 by a DVAP-P58S-mediated dominant-negative mechan-
ism induces cell degeneration by an upregulation of
PtdIns4P, which is also responsible for the observed disruption
of fundamental biological processes at the NMJs (Fig. 8C).
We and others have previously shown that transgenic ex-
pression of DVAP proteins carrying the equivalent ALS8
mutations in Drosophila mimic the human disease (3,6,9).
Notably, expression of hVAPB in flies rescues the lethality
and the phenotypes associated with DVAP mutants, indicating
an evolutionarily conserved function for VAP proteins (6).
Collectively, these data indicate that DVAP-mediated mo-
lecular pathways are likely to be important for our understand-
ing of the disease pathogenesis in humans.
DVAP and Sac1 interact to control PtdIns4P levels
There is evidence supporting that DVAP functions to maintain
normal cellular levels of PtdIns4P by interacting with Sac1.
First, Sac1 and DVAP bind to each other and colocalize in
many different tissues. It has been reported that phosphoinosi-
tol transfer proteins/phosphoinositide-binding proteins associ-
ate directly with phosphatases and kinases to control their
activities (39,42,43). Specifically, VAP has been shown to
bind PtdIns4P in vitro (44) and to be required for Sac1 activity
in yeast (39). Second, PtdIns4P levels are upregulated in
DVAPRNAi mutants, suggesting that DVAP function is
required for normal PtdIns4P levels. Similarly, in yeast, inacti-
vation of Scs2/Scs22 VAP genes induces an increase in the
levels of PtdIns4P (39,45). Third, the phenotypic similarity
associated with either DVAP or Sac1 loss-of-function muta-
tions supports the idea that the pool of PtdIns4P that is upre-
gulated in DVAP mutants is the same as the one
dephosphorylated by Sac1.
Previous studies attributed a prominent functional role to the
N-terminal MSP domain of DVAP. The MSP domain is cleaved
and secreted and binds to the extracellular domain of Ephrin
receptors (7). Secreted MSP also binds to Robo and Lar-like
receptors to control mitochondria morphology, localization
and function in muscles (8). We identified a new DVAP-
binding activity that is MSP-independent and involves a C-
terminal fragment encompassing the TM domain. Interestingly,
a new hVAPB mutation replacing valine at position 234 with an
isoleucine in the conserved TM domain of hVAPB has been
shown to cause ALS8 in humans (46). These data may
provide direct evidence of a role of hVAPB-Sac1 interaction
in the disease pathogenesis in humans.
Dynamic localization of Sac1 and ER/PM contact sites
In yeast and mammalian cells, Sac1 is an integral membrane
protein localized to the ER and the Golgi (17,36,47). Here
we report a similar localization for the Drosophila homologue
of Sac1. In yeast and mammalian cells, Sac1 localization
Figure 5. DVAP-P58S-mediated neurodegeneration is rescued by downregu-
lating either PI4KIIIa or Fwd PI4-kinases. (A) Stereo microscope images,
(B) frontal sections and (C) scanning electron micrographs of adult fly eyes
of the following genotypes: controls (ey-Gal4/+), ey,DVAP-P58S, ey,
DVAP-P58S/PI4KIIIaRNAi and ey,DVAP-P58S;FwdRNAi. Whereas control
eyes are composed of ommatidia and regularly spaced mechanosensory bris-
tles (C), ey,DVAP-P58S eyes are smaller (A) with missing (arrowhead in
C), supernumerary (black arrow in C) bristles and occasionally fused omma-
tidia. In (B), white arrow points to tissue degeneration. The ey,DVAP-
P58S-mediated neurodegeneration is rescued by downregulating either
PI4KIIIa or Fwd. (D) Quantification of the eye surface area of every genotype.
The reduced eye size of ey,DVAP-P58S flies is significantly suppressed by
coexpressing either PI4KIIIa (ey,DVAP-P58S/PI4KIIIaRNAi) or FwdRNAi
(ey,DVAP-P58S;FwdRNAi). Bar ¼ 50 mm in (A) and (B) and 10 mm in (C).
Error bars denote SEM. n ¼ 25 eyes per genotype. ∗∗∗P , 0.001.
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appears to be very dynamic, as this protein shuttles between
ER and Golgi upon nutrient conditions. Specifically, glucose
starvation in yeast or growth factor deprivation in mammalian
cells causes relocalization of Sac1 from the ER to the Golgi
complex, where it reduces PtdIns4P levels and slows protein
trafficking (38). The ER–Golgi shuttling ability of Sac1 is
reversed when nutrients or growth factors are added back to
the growth medium (38). The growth factor-induced transloca-
tion of Sac1 from the Golgi to the ER requires p38 MAPK
(mitogen-activated protein kinase) activity (48). These data
suggest that Sac1 trafficking may be regulated by stressors
that activate p38 MAPK. Some of these stressors such as oxi-
dative damage and ER stress are triggers of neurodegeneration
(49). This raises the intriguing possibility that a p38
MAPK-activated mechanism of PtdIns4P spatial regulation
may be implicated in neurodegenerative processes.
A paper published after our paper was submitted revealed
that Scs2/Scs22 VAP proteins in yeast play a pivotal role in
tethering the ER to the PM to form ER/PM contact sites
(45). Recent studies have highlighted the role of membrane
junctions between organelles as important sites for lipid me-
tabolism and intracellular signalling controlled by PtdIns4P
(50). Depletion of Scs2/Scs22 VAP proteins located to the
ER/PM contact sites leads to a retraction of the ER into intern-
al structures, elevated levels of PtdIns4Ps at the PM and induc-
tion of the UPR (45). At the ER/PM contact sites, Sac1
dephosphorylates PtdIns4P on the PM in trans from the ER
(39). This reaction requires the Scs2/Sc22p VAP proteins
and the oxysterol-binding homology proteins that act as
PtdIns4P sensors and activates Sac1 phosphatase activity
(39). ER/PM junctions have been described in many organ-
isms and cell types, including neurons and Drosophila photo-
receptors (51,52). In addition, VAP proteins have been
implicated in ER–Golgi, ER–endosomes and ER–mitochon-
dria contacts in mammalian cells, suggesting that they may
function as a tether for several organelle/membrane contact
sites (53–55).
In conclusion, emerging evidence suggests that VAP pro-
teins may be a crucial component of a hub controlling
PtdIns4P metabolism in yeast and possibly, in higher eukar-
yotes as well.
The role of PtdIns4P in synaptic physiology
and neurodegeneration
The ability of eitherPI4KIIIa orFwd to suppress the synaptic and
neurodegenerative phenotypes associatedwith transgenic expres-
sion ofDVAP-P58S is somewhat surprising, as their yeast homo-
logues (Stt4 and Pik1, respectively) are supposed to play
non-redundant functions and to control spatially separate pools
of PtdIns4P. This is based on previously published data
showing that, in yeast, Stt4 andPik1 are both essential for cell via-
bility but control different cellular processes (56–58). Pik1 is es-
sential for anterograde vesicular trafficking (59), whereas Stt4
plays a role in actin cytoskeleton organization and protein
kinase C signalling (57). Both Pik1 and Stt4 play distinct roles
in regulating MAPK signalling (60,61). Localization studies
further suggest that Pik1p is primarily present in the nucleus
and in the Golgi, whereas Stt4p is mainly cytoplasmic and is
recruited to thePMfor localized synthesis ofPtdIns4P (56,57,59).
Figure 6. Suppression of DVAP-P58S-mediated neurodegeneration by FwdRNAi and PI4KIIIaRNAi correlates with a decrease in PtdIns4P levels. (A–E) Rep-
resentative confocal images of eye imaginal discs stained with an antibody specific to PtdIns4P phosphoinositides from ey-Gal4/+ control larvae in (A),
ey,DVAP-P58S larvae in (B), ey,DVAP-P58S/GFP larvae in (C), ey,DVAP-P58S/ PI4KIIIaRNAi larvae in (D) and ey,DVAP-P58S;FwdRNAi larvae in (E).
The control levels of PtdIns4P are barely detectable in our experimental conditions, but there is a massive upregulation of PtdIns4P levels in ey,DVAP-P58S
eye imaginal discs. A decrease in PtdIns4P levels is observed when either the PI4KIIIa or Fwd kinases are downregulated in eye imaginal discs expressing
DVAP-P58S, whereas coexpression of a GFP transgene has no effect. Bar ¼ 50 mm.
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However, at present, the precise degree to which Stt4 and
Pik1 functions have been conserved and apportioned among
their homologues in flies remains unclear.
In Drosophila, the Stt4 homologue PI4KIIIa is required for
oocyte polarization and its intracellular localization has not
been determined (62). On the other hand, previous studies
revealed that the fly Pik1 homologue Fwd is required for
male germ-line cytokinesis (63). In spermatocytes, Fwd loca-
lizes to the Golgi and it is required for the accumulation of
PtdIns4P on this organelle, implying that its function in pro-
viding PtdIns4P in the Golgi is evolutionarily conserved
with yeast (64). However, whereas Pik1 is required for cell
viability, Fwd appears to be dispensable for normal develop-
ment, suggesting that it is redundant with similar genes in car-
rying out its function (56,64–66).
Another way to explain the rescue data would be to admit
that upregulation of PtdIns(4,5P)2 and not PtdIns4P is respon-
sible for DVAP-P58S mutant phenotypes.
PtdIns4P formed by the PM-associated STT4 can function
as a substrate of PI4P 5-kinase to generate PtdIns(4,5)P2 at
the cell cortex (15). It is also possible that PtdIns4P that is
phosphorylated by plasmalemmal PI4P 5-kinase originates
from intracellular sources. In the Golgi, PtdIns4P levels play
a central role in the formation of vesicles delivered from the
trans-Golgi network to the PM and their lipid cargo could be
the substrate for the plasmalemmal PtdIns(4,5)P2 synthesis
(67). As PtdIns4P in the Golgi is mainly produced by Pik1
is therefore possible that PtdIns(4,5)P2 associated with the
PM and its effector proteins are downstream of both Stt4
and Pik1. Moreover, upregulation of PtdIns(4,5)P2 would
explain the MT phenotypes, the mislocalization of post-
synaptic markers and the axonal transport defects. Indeed,
PtdIns(4,5)P2-enriched microdomains in the PM have been
shown to participate in the regulation of MT plus-end
capture and stabilization during polarized mobility (68). In
Caenorhabditis elegans, the microtubular motor UNC-4
Figure 7. Downregulation of Fwd PI4-kinase in neurons rescues the DVAP-P58S presynaptic phenotypes. (A–C) Representative confocal images of NMJs
stained for HRP and Futsch in OK6-Gal4/+control (A), in OK6/DVAP-P58S larvae (B) and in OK6/DVAP-P58S;FwdRNAi larvae (C). (D–F) Representative
confocal images of nerves stained for HRP and Brp antibodies in OK6-Gal4/+ control (D), in OK6/DVAP-P58S larvae (E) and in OK6/DVAP-P58S;FwdRNAi
larvae (F). (G) Quantification of bouton size at muscle 12 (type I and type III boutons) of segment A3 in OK6-Gal4/+ control, OK6/DVAP-P58S and OK6/
DVAP-P58S;FwdRNAi NMJs (n ¼ 205, 149, 286, respectively). (H) Quantification of total number of boutons on muscle 12 and 13 of segment A3 in
OK6-Gal4/+ controls (287.4+3.2, n ¼ 10), OK6/DVAP-P58S (160.9+1.4, n ¼ 10) and OK6/DVAP-P58S;FwdRNAi (265+3, n ¼ 10) NMJs. The decrease
in number of boutons and the increase in their size in OK6/DVAP-P58S are significantly rescued by downregulating Fwd (P , 0.0001 in every case). Presynaptic
downregulation of Fwd kinase rescues the morphological, the MT and the axonal transport phenotypes associated with both DVAP-P58S presynaptic downre-
gulation. Bar ¼ 10 mm. Error bars denote SEM. ∗∗∗P, 0.0001.
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gene was shown to be anchored to synaptic vesicles, using a
pleckstrin homology domain, thus implicating PtdIns(4,5)P2
in MT-based intracellular motility (69). Finally, spectrin pro-
teins and adducin require PtdIns(4,5)P2 for their correct local-
ization to the cell cortex (29,31).
However, if this were true, we should observe an increase in
PtdIns(4,5)P2 levels wherever we observe an upregulation of
PtdIns4P. By using an antibody specific for PtdIns(4,5)P2, we
quantified PtdIns(4,5)P2 levels in tissues in which either Sac1
or DVAP were downregulated as well as in tissues expressing
the DVAP-P58S transgene. Surprisingly, PtdIns(4,5)P2 levels
were not affected by the dramatic upregulation of PtdIns4P in
any of the genotypes described earlier. Consistent with these
data, it was previously reported that, inDrosophila eye imaginal
discs, depletion of Sac1 exhibits a dramatic increase in PtdIns4P
levels, whereas PtdIns(4,5)P2 and PtdIns3P levels remain
similar to wild-type (41). In addition, a paper published after
our paper was submitted and another paper published a few
months earlier showed that loss of PMPtdIns4P by downregula-
tion ofPI4KIIIawas not matched by a decrease in PtdIns(4,5)P2
levels (70,71). They showed that the major function of PtdIns4P
is not to generate the pool of PtdIns(4,5)P2 on the PM but rather
to contribute to the generation of a polyanionic lipid environ-
ment in the inner leaflet of the PM. PtdIns4Pwould then function
in recruiting soluble proteins to the PM by electrostatic inter-
action with their polycationic surface. They also show that
PtdIns4P contributes to processes such as modulation of ion
channel activity that have been traditionally associated with
changes in PtdIns(4,5)P2 (71). Finally, upregulation of
PtdIns(4,5)P2 by inactivation of the Drosophila PI(4,5)P2 5-
phosphatase synaptojanin leads to a distinct endocytotic pheno-
type due to defects in synaptic vesicle recycling. In synaptojanin
mutants, synaptic vesicles are severely depleted and those
remaining are clearly clathrin-coated. Intracellular recordings
revealed enhanced synaptic depression during prolonged high-
frequency stimulation (72). Ultrastructural and electrophysio-
logical analysis ofDVAPmutants do not exhibit a synaptojanin-
like phenotype (6,9 and G. Pennetta, unpublished data), indicat-
ing that upregulation of PtdIns(4,5)P2 does notmimic the pheno-
type associated with increased levels of PtdIns4P.
Taken together, these considerations suggest that increased
levels of PtdIns4P could be the main factor determining the
observed synaptic and neurodegenerative phenotypes. Further
studies using fluorescent phosphoinositide probes and genetic
analyses will be needed to fully clarify the contribution of
PtdIns4P versus PtdIns(4,5)P2 pools to NMJ physiology and
neurodegeneration.
The role of DVAP–Sac1 interaction in lipid transport
Emerging evidence indicates that VAP and Sac1 may also play
an important and specific role in membrane homeostasis (73).
Figure 8. Sac1 is sequestered into DVAP-P58S-mediated aggregates. (A) Eye imaginal discs and (B) brains stained for both DVAP and Flag in ey,DVAP-P58S/
Flag-Sac1 and elav;DVAP-P58S/Flag-Sac1 larvae. Bar ¼ 10 mm. (C) Graphical summary of the data. The left panel shows a chemical equilibrium between two
reactions: one in which Sac1 interacts with DVAP to catalyse the conversion of PtdIns4P into PtdIns and another in which PI4K converts PtdIns into PtdIns4P.
The right panel shows that depleting DVAP (i) or Sac1 (ii) or the aggregation of Sac1 and DVAP into DVAP-P58S-induced aggregates (iii) inhibits Sac1-
mediated reaction leading to an increase in PtdIns4P levels.
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Biogenesis of sphingolipids, sterols and phosphoinositides that
together determine the structural and functional properties of
cell membranes must be closely coordinated. VAP interacts
with both oxysterol-binding protein (OSBP) and ceramide
transfer protein (CERT), recruiting them to contact sites
between the ER and the Golgi complex (74). CERT has a
FFAT (diphenylalanine in an acidic tract) motif that mediates
its binding to ER-localized VAP and a PH domain that recog-
nizes the PtdIns4P-enriched Golgi membrane. It has been pro-
posed that CERT, because of its dual-binding ability, shuttles
ceramide from the ER to the Golgi, where it is converted into
sphingomyelin (75). Sphingomyelin continues to move
through the secretory pathway to the PM, where it is most
abundant. OSBP has an analogous function to CERT but
instead mediates inter-membrane sterol transfer. This func-
tional similarity is also reflected in OSBP’s domain architec-
ture: like CERT, it contains a PtdIns4P-binding PH domain
and a VAP-binding FFAT motif (76). Ridgway and Perry
(74) showed that sterols regulate sphingolipid metabolism
by inducing a significant increase in SM synthesis that is de-
pendent on OSBP, CERT and their shared binding partner
VAP. The precise mechanism is not yet known but OSBP
appears to activate CERT by promoting its recruitment to
membranes and its binding to VAP. It is likely that disruption
of the VAP–Sac1 interaction may have profound effects on
the lipid composition of the PM, affecting its curvature and
thickness and by consequence, vesicle budding and membrane
remodelling (77). Interestingly, synaptic growth requires
membrane remodelling and, at the Drosophila NMJs, occurs
mainly by the budding of new boutons from pre-existing
ones (78).
Putative roles of PtdIns4P in neurodegeneration
VAPB is involved in the IRE1/XBP1 signalling pathway of the
UPR, an ER reaction inhibiting the accumulation of unfolded/
misfolded proteins. In the disease-context, the hVAPB-P56S
protein recruits its wild-type counterpart into the aggregates
and it attenuates its ability to induce the UPR (10). This together
with the observation that, in yeast, depletion of VAP proteins
from the ER/PM contact sites induces a constitutive activation
of the UPR suggests that motor neurons in ALS8 could be par-
ticularly vulnerable to cell death-induced ER stress. In addition,
VAP proteins have been shown to be involved in lipid transfer
and metabolism and accumulation of lipids and intermediates
of lipid biosynthetic pathways are potent inducers of apoptosis
(79). Finally, recent studies in yeast have shown that defects
in the PtdIns4K Pik1 activity lead to a blockage of autophagy,
a process controlling the degradation of long-lived proteins,
damaged organelles and bulk cytoplasm in response to various
types of stress (80).
Many questions remain to be explored concerning the
precise molecular mechanism underlying neurodegeneration
in ALS. However, over the last few years, an increasing
number of experimental models have been generated and
they represent an excellent tool for identifying molecular path-
ways in ALS and for evaluating their contribution to the
disease pathogenesis.
MATERIALS AND METHODS
Drosophila stocks
Flies were raised on standard cornmeal food at 258C. The fol-
lowing strains were used: elav-Gal4, ey-Gal4, OK6-Gal4,
BG57-Gal4 and UAS-DIAP1 and the DVAPRNAiJF02621 (Bloo-
mington Drosophila Stock Center) and Sac12107 (19).
Sac1RNAi, PI4KIIIaRNAi, DVAPRNAiGD3990 and FwdRNAi
stocks were obtained from the VDRC. For the DVAPR-
NAiJF02621 line, the P{TRiP.JF02621} construct was used and
the target sequence is in the 3′ UTR of the cDNA, whereas
the P{GD3990} construct used for the DVAPRNAiGD3990
line has a target sequence located within the ORF of the
DVAP cDNA (http://flybase.org).
Immunohistochemistry
NMJs from wandering third-instar larvae were dissected in
cold PBS before fixation and staining as previously described
(5). The PtdIns4P staining and PtdIns(4,5)P2 staining were
performed as previously reported (41) with tissue-specific
modifications. For PtdIns4P and PtdIns(4,5)P2 staining,
tissues were fixed with 4% paraformaldehyde in PBS for
30 min, then washed in PBS and quenched with 50 mM
NH4Cl in PBS for 10 min, before washing. Salivary glands
were permeabilized in TBS + 0.5% saponin (Sigma) for 1 h
at room temperature before blocking overnight in TBS with
0.3% saponin and 10% NGS at 48C. Primary antibodies
were used at 1:100 in permeabilization buffer containing 5%
NGS for 2 h at room temperature. Primary and secondary anti-
body washes were carried out in TBS containing 0.3% saponin
and 1% NGS. Eye imaginal discs were processed similarly
with a 3 h permeabilization and 4 h primary antibody incuba-
tion time. Larval brains and NMJs were processed similarly
except that the permeabilization and the incubation with the
primary antibody were performed overnight at 48C.
Mousemonoclonal antibodies for Futsch, Adducin, dCSP, Brp
and DLG were all used at a concentration of 1:50. Other anti-
bodies were used at the following concentrations: anti-b-spectrin
at 1:500, rabbit anti-DLG at 1:8000, anti-Boca at 1:1000, anti-
DVAP at 1:1000, anti-GM130 (Abcam) at 1:100, anti-Flag
(Sigma) at 1:100 and anti- PtdIns4P (Echelon) at 1:100. Goat
anti-HRP (1:200), rabbit anti-HRP (1:500) and all secondary anti-
bodies (1:500) were purchased from Jackson ImmunoResearch.
Samples were mounted on microscope slides using Vectashield
mounting medium (Vector Laboratories).
Eye histology and scanning electron microscopy
Frontal sections and scanning electron microscopy of adult fly
eyes were processed as previously described (3).
Molecular biology
To generate the N-terminal Flag-tagged Sac1 (Flag-Sac1)
construct, the full-length Sac1 cDNA was amplified from
clone GH08349 with PCR primers containing BamHI
and SalI sites and cloned in-frame into the pCMV-Tag2b
vector (Clontech). The Flag-Sac1 fragment was then cloned
into the pUAST vector using NotI and KpnI sites. For
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co-immunoprecipitation experiments, the Myc-Sac1 construct
was generated by PCR amplification of the full-length Sac1
cDNA, using primers containing SalI and KpnI. The resulting
fragment was cloned in-frame into pCMV-Myc vector (Clon-
tech). The Flag-tagged DVAP (Flag-DVAP) construct was
generated by amplifying the full-length DVAP cDNA with
PCR primers containing EcoRI and SalI sites and by cloning
the resulting DNA fragment in-frame into the pCMV-Tag2b
vector. The DVAP-P58S construct was cloned into the
pCMV-Tag2b vector, using the same strategy as for the
cloning of DVAP cDNA in the same vector. For immunocyto-
chemistry, a Myc-DVAP construct was generated by PCR
amplification of the full-length DVAP cDNA, using EcoRI
and NotI primers and cloned in-frame into pCMV-Myc
vector (Clontech). For the same experiment, the Flag-Sac1
fragment was cloned into the pCMV-Tag2b vector as
described earlier. For the semiquantitative PCR amplification,
total RNA was purified from 20 dissected brains of the rele-
vant genotypes and collected in TRIzol reagent (Sigma).
cDNAs were produced using oligo-dT primers and following
the manufacturer’s instructions (SuperScript III First Strand
Kit, Invitrogen). Amplification of Rp49 cDNA was made
using the following primers: Rp49-L: CCGACCACGTTAC
AAGAACTCTC; Rp49-R: CGCTTCAAGGGACAGTATCT
GA. For the amplification of Sac1 cDNA, the following
primers were used: Sac1-L: TGCTGGGAACCATTCACCTA
and Sac1-R: TGGCACTGACAGCG ATCATT. In both
cases, PCR conditions were in the linear part of amplification.
At least three different samples for each genotype were ana-
lysed. PCR products were visualized with ethidium bromide
on a gel. For the Sac1D construct, the deletion of the
RTNCIDCLDRTN catalytic motif was introduced into Sac1
cDNA (GH08349 clone) by site-directed mutagenesis using
QuikChange IIXL Site-Directed Mutagenesis Kit (Agilent
Technologies) and following the manufacturer’s instructions.
The Sac1cDNA carrying the RTNCIDCLDRTN motif dele-
tion was isolated by PCR amplification and cloned into
pUAST vector, using BamHI–KpnI linkers. Basic molecular
biology techniques were performed following standard
protocols.
Co-immunoprecipitation and immunocytochemistry
Cells were cultured in DMEM medium containing 10% FBS
until 80% confluent and transfected with the relevant plas-
mids, using FuGENE Transfection Reagent (Roche) according
to the manufacturer’s instructions. Protein lysates for co-
immunoprecipitation were prepared as previously described
in Kawano et al. (81), with minor modifications. The protein
complexes were immunoprecipitated using anti-Myc beads
from Pierce Profound c-Myc Tag IP/Co-IP Application Set
(Thermo Scientific). Inputs, precipitated protein complexes
and supernatants were analysed by SDS–PAGE and western
blots. Detection of Flag-DVAP proteins by western blot was
performed by using a guinea pig anti-DVAP antibody at a con-
centration of 1:40 000 and a secondary HRP-conjugated anti-
guinea pig antibody at 1: 60 000. Myc-Sac1 proteins were
detected by western blot using a rabbit anti-Myc (Sigma) anti-
body at a concentration of 1:10 000 and an anti-rabbit
HRP-conjugated secondary antibody at 1:30 000. For
immunocytochemistry, cells were plated on BioCoatTM
poly-L-lysine glass coverslips (BD Biosciences) and trans-
fected as described earlier. Confluent cells were fixed in 4%
paraformaldehyde for 20 min, blocked in PBS-T containing
10% NGS and incubated overnight with both rabbit
anti-Myc (Sigma, 1:200) and mouse anti-Flag (Sigma,
1:200) antibodies. Fluorescent secondary antibodies were
used at 1:500. Preparations were mounted in Vectashield
medium.
Genetics and transgenics
Lethal transgenic insertions were maintained over GFP-con-
taining balancers to select the relevant genotypes for larval
phenotypic analysis. Transgenic lines were generated using
standard protocols. To characterize the mutant phenotypes,
Gal4 drivers were crossed with the transgenic lines. Embryos
were collected for 20–24 h and then transferred to a water-bath
at 308C to maximize the expression of the transgene. The
ey-Gal4 driver was recombined with DVAP-P58S on the same
chromosome, following standard procedures.
Yeast two-hybrid assay
Binary interactions between DVAP and Sac1 were performed
using the MATCHMAKER 3 GAL4 Yeast Two Hybrid
System (Clontech). The full-length cDNA for DVAP was
cloned in-frame into the pGADT7 vector, using PCR primers
containing EcoRI and BamHI sites. Full-length cDNA for
Sac1 was cloned in-frame into the pGBKT7 vector, using
PCR primers containing NdeI and BamHI sites. All other frag-
ments were cloned in-frame by PCR, using primers containing
NdeI and BamHI sites. DVAP constructs lacking the CC and
TMs were generated by using the QuikChange II XL Site-
Directed Mutagenesis Kit (Agilent Technologies) and following
the manual’s instructions. Protein interactions were analysed
in media lacking histidine, adenine, leucine and tryptophan
(2HALT medium) following transformation in AH109 yeast
strain with the relevant plasmids.
Statistical analysis
Statistical analysis was performed and graphs were generated
using GraphPad 5.0. The D’Agostino and Pearson omnibus
test was applied to check for normality in the distributions
of samples. For experiments with more than two samples
which all passed the normality test, a one-way ANOVA test
was applied to the samples. Tukey’s multiple comparison
test was then used as a post hoc-test when a significant differ-
ence was found in the ANOVA test. For experiments with
more than two samples where at least one did not pass the nor-
mality test, statistical analysis was performed using the
Kruskal–Wallis test and the Dunn’s multiple comparison
test as a post-test. For experiments with only two samples
and where at least one of the two did not pass the normality
test, statistical significance was evaluated using the Mann–
Whitney U-test. Finally, for experiments with only two
samples that both passed the normality test, a two-tailed un-
paired Student’s t-test was applied.
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Imaging analysis and quantification
For imaging and quantification, NMJs, brains, eye imaginal
discs and salivary glands from wandering third instar larvae
were dissected and immunostained with the appropriate anti-
bodies. Preparations were imaged on a Zeiss Axiovert
LSM510 confocal microscope. The same confocal gain set-
tings were applied to controls and samples. For all the
images, the gain was chosen at the maximum gain that did
not saturate the signal for each sample. Images were processed
with the LSM software and Adobe Photoshop. Quantification
of bouton number was performed by counting the total
number of boutons on muscle 12 and 13 of the segment A3.
The size of boutons was analysed by measuring the surface
area of type I and type III boutons on muscle 12 of segment
A3 and represented as ratio between the number of boutons
with a given range of sizes and the total number of boutons
(relative frequency). For the quantification of the axonal trans-
port phenotype and PtdIns(4,5)P2 levels, a complete Z-stack
was acquired and rendered as a maximum projection.
Common appropriate intensity thresholdswere selected to prop-
erly identify specific signals and ignore background intensities
in the ImageJ package. The average number of detectable Brp
puncta was quantified in 100 mm lengths of segmental nerves
by using ImageJ. For the PtdIns(4,5)P2 levels, detectable
puncta in 104 mm2 surface areas were quantified. Semi-
quantitative analysis of the colocalization was performed and
Pearson’s overlap coeffcient was obtained with the JACoP
plugin for ImageJ (82). Characterization of phenotypes in
which elav-Gal4 was used as a driver was performed between
gender-matched animals. However, besides the case of the
Sac1 neurodegenerative phenotype, no major differences in
phenotypes were observed between males and females in any
other context in which elav-Gal4 was used as a driver.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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